🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The subsequent treatment choices for the patients with advanced melanoma, w...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2020-08-20
Trial ID
NCT04756934
LP002 is a humanized monoclonal antibody targeting programmed death ligand-...
Status
Unknown
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2020-12-30
Trial ID
NCT04600947
Treatments Being Tested
LP002 is a highly selected recombinant humanized anti-PD-L1 monoclonal anti...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2020-12-02
Trial ID
NCT04740021
Treatments Being Tested
LP002 is a humanized monoclonal antibody targeting programmed death ligand-...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2019-06-17
Trial ID
NCT04755543
Treatments Being Tested